54 Grants (Page 2 of 3)
2014
Role of PGE2 and other eicosanoids in hematopoietic stem cell function
PELUS, LOUIS M
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL096305-05), $373,527USD, 01/29/2010 -- 07/31/2015
2013
A megakaryocyte/PGE2/osteoblast triad in the normal and aged niche
Kacena, Melissa A and PELUS, LOUIS M
National Institutes of Health (NIH), National Institute on Aging (NIA) (ID: 1R01AG046246-01), $195,000USD, 09/30/2013 -- 06/30/2018
 
Role of PGE2 and other eicosanoids in hematopoietic stem cell function
PELUS, LOUIS M
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL096305-04), $362,855USD, 01/29/2010 -- 11/30/2014
2012
Role of PGE2 and other eicosanoids in hematopoietic stem cell function
PELUS, LOUIS M
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL096305-03), $381,150USD, 01/29/2010 -- 11/30/2014
2011
Role of PGE2 and other eicosanoids in hematopoietic stem cell function
PELUS, LOUIS M
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL096305-02), $385,000USD, 01/29/2010 -- 11/30/2014
2010
Role of PGE2 and other eicosanoids in hematopoietic stem cell function
PELUS, LOUIS M
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 1R01HL096305-01A1), $385,000USD, 01/29/2010 -- 11/30/2014
2009
Chemokine Induced Hematopoietic Stem Cell Mobilization
PELUS, LOUIS M
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL069669-08), $366,553USD, 08/15/2001 -- 05/31/2011
2008
Chemokine Induced Hematopoietic Stem Cell Mobilization
PELUS, LOUIS M
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL069669-07), $366,553USD, 08/15/2001 -- 05/31/2010
2007
Chemokine Induced Hematopoietic Stem Cell Mobilization
PELUS, LOUIS M
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL069669-06), $367,766USD, 08/15/2001 -- 05/31/2010
 
Role of Survivin in Blood Stem Cell Cycle and Apoptosis
PELUS, LOUIS M
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL079654-04), $321,078USD, 07/01/2004 -- 06/30/2009
2006
Chemokine Induced Hematopoietic Stem Cell Mobilization
PELUS, LOUIS M
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 2R01HL069669-05A1), $378,750USD, 08/15/2001 -- 05/31/2010
 
Role of Survivin in Blood Stem Cell Cycle and Apoptosis
PELUS, LOUIS M
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL079654-03), $330,668USD, 07/01/2004 -- 06/30/2008
2005
Role of Survivin in Blood Stem Cell Cycle and Apoptosis
PELUS, LOUIS M
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL079654-02), $338,625USD, 07/01/2004 -- 06/30/2008
2004
Chemokine induced hematopoietic stem cell mobilization
PELUS, LOUIS M
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL069669-04), $335,250USD, 08/15/2001 -- 06/30/2006
 
Role of Survivin in Blood Stem Cell Cycle and Apoptosis
PELUS, LOUIS M
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 1R01HL079654-01), $338,625USD, 07/01/2004 -- 06/30/2008
2003
Chemokine induced hematopoietic stem cell mobilization
PELUS, LOUIS M
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL069669-03), $335,250USD, 08/15/2001 -- 07/31/2005
2002
Chemokine induced hematopoietic stem cell mobilization
PELUS, LOUIS M
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL069669-02), $335,250USD, 08/15/2001 -- 07/31/2005
2001
Chemokine induced hematopoietic stem cell mobilization
PELUS, LOUIS M
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 1R01HL069669-01), $335,250USD, 08/15/2001 -- 07/31/2005
1992
REGULATION OF MYELOID PROGENITOR CELL DIFFERENTIATION
PELUS, LOUIS M
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA033225-11), 09/15/1990 -- 08/31/1993
1991
REGULATION OF MYELOID PROGENITOR CELL DIFFERENTIATION
PELUS, LOUIS M
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA033225-10), 09/15/1990 -- 08/31/1993
1989
REGULATION OF MYELOID PROGENITOR CELL DIFFERENTIATION
PELUS, LOUIS M
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA033225-08), 09/01/1985 -- 10/27/1989
 
REGULATION OF MYELOID PROGENITOR CELL DIFFERENTIATION
PELUS, LOUIS M
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 7R01CA033225-09), 09/15/1990 -- 08/31/1993
1988
REGULATION OF MYELOID PROGENITOR CELL DIFFERENTIATION
PELUS, LOUIS M
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 2R01CA033225-07), 09/01/1985 -- 07/31/1993
1987
REGULATION OF MYELOID PROGENITOR CELL DIFFERENTIATION
PELUS, LOUIS M
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA033225-06), 09/01/1985 -- 07/31/1988
1986
REGULATION OF MYELOID PROGENITRO CELL DIFFERENTIATION
PELUS, LOUIS M
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA033225-05), 09/01/1985 -- 07/31/1988